| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 8.605 | 9.993 | 14.285 | 21.327 | 18.978 | 25.382 | 19.621 |
| Total Income - EUR | - | - | - | 8.605 | 9.993 | 16.286 | 21.327 | 18.978 | 25.382 | 19.621 |
| Total Expenses - EUR | - | - | - | 4.384 | 7.125 | 2.897 | 7.485 | 8.409 | 12.980 | 20.732 |
| Gross Profit/Loss - EUR | - | - | - | 4.221 | 2.867 | 13.388 | 13.842 | 10.569 | 12.401 | -1.111 |
| Net Profit/Loss - EUR | - | - | - | 3.963 | 2.585 | 12.982 | 13.279 | 10.178 | 12.168 | -1.278 |
| Employees | - | - | - | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Proteoline S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 159 | 78 | 76 | 75 | 0 | 3.216 | 5.010 |
| Current Assets | - | - | - | 4.263 | 2.929 | 15.647 | 28.004 | 10.922 | 11.082 | 7.718 |
| Inventories | - | - | - | 319 | 0 | 0 | 0 | 0 | 0 | 674 |
| Receivables | - | - | - | 2.107 | 105 | 0 | 0 | 1.480 | 30 | 30 |
| Cash | - | - | - | 1.838 | 2.823 | 15.647 | 28.004 | 9.442 | 11.051 | 7.013 |
| Shareholders Funds | - | - | - | 4.006 | 2.636 | 15.569 | 27.835 | 10.319 | 12.317 | 10.971 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 416 | 370 | 155 | 243 | 603 | 1.980 | 1.758 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "3250 - 3250" | |||||||||
| CAEN Financial Year |
3250
|
|||||||||
Comments - Proteoline S.r.l.